Dec 12 () - Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday. Ozempic, a once-weekly injectable approved by the U.
Weight loss drug Ozempic was launched in India on Friday, with 0.25mg doses priced at $24.35 a week. Pharmaceutical company ...
Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback